The linear accelerator uses electricity to accelerate protons that are directed at a fixed target, creating neutrons in the process. The standard neutron energy range of BNCT is from 0.5 eV to 10 keV. If the energy is too low, the therapy fails to achieve its effect; if it is too high, normal cells are damaged.

IPT’s world-class linear accelerator generates 2-10 times as many neutron sources as a conventional reactor, providing stable and safe energy.  Meanwhile, the high stability of the neutron source can target cancer cells with minimal damage to healthy tissue.